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Open access under the ElsIn this study, the cytotoxicity, genotoxicity and early ROS generation of 2,2-dimethyl-(3H)-3-(N-30-nitro-
phenylamino)naphtho[1,2-b]furan-4,5-dione (QPhNO2) were investigated and compared with those of its
precursor, nor-beta-lapachone (nor-beta), with the main goal of proposing a mechanism of antitumor
action. The results were correlated with those obtained from electrochemical experiments held in protic
(acetate buffer pH 4.5) and aprotic (DMF/TBABF4) media in the presence and absence of oxygen and with
those from dsDNA biosensors and ssDNA in solution, which provided evidence of a positive interaction
with DNA in the case of QPhNO2. QPhNO2 caused DNA fragmentation and mitochondrial depolarization
and induced apoptosis/necrosis in HL-60 cells. Pre-treatment with N-acetyl-L-cysteine partially abolished
the observed effects related to the QPhNO2 treatment, including those involving apoptosis induction,
indicating a partially redox-dependent mechanism. These ﬁndings point to the potential use of the com-
bination of pharmacology and electrochemistry in medicinal chemistry.
 2012 Elsevier Ltd.Open access under the Elsevier OA license.1. Introduction
Cancer is the second leading cause of death worldwide.
Although cancer is often referred to as a single disease, it actually
consists of more than 100 different conditions. These diseases are
characterized by uncontrolled cell growth and the spread of abnor-
mal cells (Hanahan and Weinberg, 2000).
Drugs containing a quinone moiety, such as anthracyclines and
mitoxantrones show excellent anticancer activity (Foye, 1995),
which justiﬁes the numerous studies in the literature on the syn-
thesis and evaluation of either natural quinones or their analogues
as potential antitumor agents (da Silva Júnior et al., 2007, 2009,
2010; Montenegro et al., 2010). Two major mechanisms of quinonede Fisiologia e Farmacologia,
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evier OA license.cytotoxicity have been proposed: stimulation of oxidative stress
and alkylation of cellular nucleophiles, which encompass a large
range of biomolecules (Asche, 2005; de Abreu et al., 2002a; Hillard
et al., 2008), such as DNA and some enzymes, e.g., topoisomerase
and protein tyrosine phosphatases (Bova et al., 2004).
One of the most widely studied quinones is beta-lapachone, a
natural compound found in the lapacho tree that can be synthesized
easily from lapachol by acid cyclization. Beta-lapachone and its re-
lated compound nor-beta-lapachone (nor-beta, Fig. 1) are cytotoxic
to many human cancer cell lines at concentrations in the IC50 range
of 1–10 lM (da Silva Júnior et al., 2007). In a previous study, our
group demonstrated that the structural modiﬁcations of nor-beta
can enhance its anticancer activity against cancer cell lines (da Silva
Júnior et al., 2007, 2009, 2010) and that 2,2-dimethyl-(3H)-3-(N-30-
nitrophenylamino)naphtho[1,2-b]furan-4,5-dione (QPhNO2, Fig. 1)
is one of the most active substances, with an IC50 below 2 lM (da
Silva Júnior et al., 2007).
Thus, the aim of the present work was to evaluate the mecha-
nism of action involved in QPhNO2 cytotoxicity and genotoxicity
in the leukemia cell line HL-60 compared with its precursor
OO
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Fig. 1. Chemical structures of nor-beta-lapachone (nor-beta) and 2,2-dimethyl-
(3H)-3-(N-30-nitrophenylamino)naphtho[1,2-b]furan-4,5-dione (QPhNO2), antitu-
mor compounds.
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and contributed to the elucidation of the mechanism of action. This
approach is particularly suitable for states of the disease associated
with oxidative stress of cells, as in cancer (de Souza et al., 2010;
Hileman et al., 2004). Additionally, this electrochemical approach
can provide an understanding of the interaction between antican-
cer drugs and DNA, yielding information on the extent of DNA
damage (de Abreu et al., 2008; Oliveira-Brett et al., 2002; Rauf
et al., 2005).
2. Experimental
2.1. Materials
2,2-Dimethyl-(3H)-3-(N-30-nitrophenylamino)naphtho[1,2-b]
furan-4,5-dione (QPhNO2, C20H16O5N2, molecular mass 364.35 g/
mol) was prepared as described previously (da Silva Júnior et al.,
2007). Stock solutions for pharmacological assays were prepared
by dissolving QPhNO2 and nor-beta in 0.1% DMSO immediately
prior to use. Doxorubicin hydrochloride (adriamycin, CAS No.
25316-40-9) (Dox) was purchased from Sigma Aldrich Co. (St.
Louis, MO, USA). RPMI 1640 growth medium supplemented with
2% glutamine, fetal bovine serum, streptomycin and penicillin
was purchased from Gibco (Invitrogen, Carlsbad, CA, USA). Calf
thymus dsDNA (sodium salt, type I) was purchased from Sigma
(St. Louis, MO, USA). Aqueous acetate buffer solutions (0.1 M, pH
4.5), which were used in the electrochemical experiments involv-
ing DNA, were prepared from analytical grade reagents and puri-
ﬁed water (conductivity < 0.1 lS/cm) obtained from a Millipore
(Milford, MA, USA) Milli-Q system. Dimethylformamide (DMF)
and tetrabutylammonium tetraﬂuoroborate (TBABF4) were used
in the electrochemical experiments (aprotic medium) and pre-
pared from analytical grade reagents supplied by Sigma Aldrich.
2.2. HL-60 cell culture and MTT assay
HL-60 cells (human promyelocytic leukemia line) were grown
in RPMI-1640 medium supplemented with 10% fetal bovine serum,
100 lg/mL streptomycin and 100 U/mL penicillin at 37 C in a 5%
CO2 atmosphere. The cytotoxicity of compounds (0.009–5 lg/mL)
was evaluated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphe-
nyl-2H-tetrazolium bromide (MTT) reduction assay (Mosmann,
1983) after 24 h of incubation. Doxorubicin was used as a positive
control. In a second set of experiments, N-acetyl-L-cysteine (NAC,
5 mM) was pre-incubated with the cells for 1 h before drug addi-
tion, and after 24 h, cytotoxicity was measured, as previously
described.
2.3. Analysis of mechanisms involved in the cytotoxic activity
Additional experiments were performed to elucidate the mech-
anisms involved in the cytotoxic action of nor-beta and QPhNO2
using HL-60 cells (3  105 cells mL1) after drug exposure for24 h. Compounds were dissolved in DMSO to make a 1 mg mL1
stock solution and added to the cell culture to obtain a ﬁnal con-
centration of 0.5, 1.0 or 2.0 lM QPhNO2, based on its IC50 value,
or 1.0 or 2.0 lM nor-beta. Doxorubicin (0.5 lM) was used as a po-
sitive control.
2.3.1. Measurement of the generation of reactive oxygen species
After the quinone treatment, cells were loaded with 20,70-
dichlorodihydroﬂuorescein diacetate (H2-DCF-DA) (20 lM) and
incubated at 37 C for 30 min in the dark, as proposed by Lebel
et al. (1992). Doxorubicin and beta-lapachone were used as posi-
tive controls. The experiments were repeated in the presence of
NAC (5 mM) pre-incubated with the cells for 1 h before drug addi-
tion. The cells were then harvested, washed, resuspended in PBS
and analyzed immediately by ﬂow cytometry at excitation and
emission wavelengths of 490 and 530 nm, respectively.
2.3.2. Flow cytometry analysis
All experimental procedures adopted in the ﬂow cytometry
analysis essentially followed the methodology described by Mon-
tenegro and coworkers (2010). The evaluated parameters included
cell membrane integrity, internucleosomal DNA fragmentation,
cell cycle, mitochondrial depolarization, phosphatidylserine (PS)
externalization and caspase 3/7 activation. For all the tested com-
pounds, ﬁve thousand events were evaluated per experiment, and
cellular debris was omitted from the analysis. HL-60 cell ﬂuores-
cence was then determined by ﬂow cytometry in a Guava EasyCyte
Mine using Guava Express Plus software. Internucleosomal DNA
fragmentation and the cell cycle were analyzed by ModFit LT for
Win32 version 3.1. The experiments were performed in triplicate.
To verify the participation of ROS in the quinone activity, NAC
(5 mM) was pre-incubated with the cells for 1 h prior to drug addi-
tion, and after 24 h, cell membrane integrity, internucleosomal
DNA fragmentation and phosphatidylserine (PS) externalization
were measured, as previously described.
2.4. DNA gel electrophoresis
During the apoptotic process, DNA is cleaved in a distinctive
way at internucleosomal sites by a speciﬁc caspase-activated endo-
nuclease, thus yielding fragments in multiples of 200 bp, which ap-
pear as a characteristic ‘‘ladder’’ when DNA is separated by gel
electrophoresis (Enari et al., 1998). Fragmented DNA was isolated
as described by Ausubel et al. (1990), using DNAzol Reagent (Gib-
co – Invitrogen, Carlsbad, CA, USA) after 24 h of incubation. Elec-
trophoresis was performed in a 1.5% agarose gel.
2.5. Comet assay in HL-60 cells
The alkaline comet assay was performed as described by Singh
et al. (1988) with minor modiﬁcations. Brieﬂy, HL-60 cells were
incubated for 3 or 24 h with ﬁve concentrations of QPhNO2 (0.5,
1.0, 2.0, 5.0 or 10 lM) and with nor-beta at 2.0 or 10 lM. Then,
the cells were processed and dissolved in 0.75% low melting point
agarose and immediately spread onto a glass microscope slide pre-
coated with a layer of 1% normal melting point agarose. The slides
were further incubated in ice-cold lysis solution (pH 10.0) at 4 C
for at least 1 h. After the lysis procedure, the slides were placed
in a horizontal electrophoresis unit ﬁlled with enough fresh buffer
(300 mM NaOH and 1 mM EDTA, pH 13.0) to cover the slides for
20 min at 4 C. Electrophoresis was conducted for 20 min at 25 V
(300 mA). The slides were then neutralized (0.4 M Tris, pH 7.5)
and ﬁxed with ethanol 100%. After the staining step with ethidium
bromide, the gels were dried at room temperature overnight, and
50 cells from each of two replicate slides were selected and ana-
lyzed for each concentration of test substance. These cells were
Table 1
Growth inhibitory activity expressed by IC50 (lM) of compounds for HL-60 cell line in
the absence or in the presence of N-acetylcysteine (NAC, 5 mM) after 24 h of
incubation. NAC was pre-incubated with the cells 1 h before the tested compounds.
Compounds IC50 (lM)a
Without NAC +NAC (5 mM)
Nor-beta 2.01 ± 0.17 2.72 ± 0.08*
QPhNO2 0.32 ± 0.04 1.03 ± 0.10*
Doxorubicin 0.20 ± 0.002 0.31 ± 0.05
aData are presented as mean IC50 values ± standard error of the mean from 3 to 4
independent experiments. Doxorubicin was used as a positive control.
* p < 0.05, comparing values in the absence or in the presence of NAC by Student t
test.
A.J. Araújo et al. / Toxicology in Vitro 26 (2012) 585–594 587scored visually into ﬁve classes according to tail length: (1) class 0:
undamaged, without a tail; (2) class 1: with a tail shorter than the
diameter of the head (nucleus); (3) class 2: with a tail length 1–2
the diameter of the head; (4) class 3: with a tail longer than 2 the
diameter of the head; and (5) class 4: comets with no heads. The
damage index is based on the length of migration and the amount
of DNA in the tail and is considered a sensitive measure of DNA.
The damage index thus ranged from 0 (completely undamaged:
100 cells  0) to 400 (with maximum damage: 100 cells  4). The
vehicle was used as a negative control, and doxorubicin (0.5 lM)
was used as a positive control.
2.6. Electrochemical approaches
Electrochemical experiments, including cyclic voltammetry
(CV) and differential pulse voltammetry (DPV), were performed
using an Autolab (Echo-Chemie, Utrecht, Netherlands) PGSTAT 20
or PGSTAT-30. The working electrode was a BAS (Bioanalytical Sys-
tems, West. Lafayette, IN, USA) 3-mm diameter GC electrode, the
counter electrode was a platinum coil, and the reference electrode
was AgAgCl, Cl (0.1 M); all of the electrodes contained in a single-
compartment electrochemical cell with a 10-mL capacity. In CV
experiments, a scan rate of 0.100 V s1 was chosen for comparison
and for ﬁgures. It was only necessary to degas the cell with a nitro-
gen ﬂux for reduction studies.
CV experiments were performed with QPhNO2 and nor-beta in
aprotic media (DMF + 0.1 M TBABF4) on a glassy carbon electrode
in the absence and presence of oxygen to investigate their electro-
chemical reduction mechanisms and possible oxygen interaction
with the electrochemically generated radical anions, at EpIc (from
QPhNO2 and nor-beta). The parameters analyzed were the ob-
served anodic shift in the potential of the ﬁrst reduction wave
(EpIc) and the current increase on the same peak (IpIc). Each com-
pound was added to the supporting electrolyte, and the solution
was degassed with N2, with a subsequent CV run. Oxygen was then
bubbled into the cell, and its concentration was monitored with an
oxymeter (DM-4 Digimed). Cyclic voltammograms were recorded
at different oxygen concentrations.
For reduction and oxidation studies in protic media, the CV and
DPV of 0.1 and 1 mM solutions of QPhNO2 and nor-beta (previously
dissolved in 1 mL ethanol) in acetate buffer (0.1 M, pH 4.5) were
performed using a bare GC electrode. For the DPV measurements,
the optimized differential pulse voltammetry parameters were as
follows: pulse amplitude (DEsw) of 50 mV, pulse width of 70 ms
and scan rate of 5 mV s1 [using a step potential (DEs) of
0.002 V]. This supporting electrolyte was used for all of the exper-
iments involving DNA. All experiments were performed at room
temperature (25 ± 1 C).
2.7. Preparation of the dsDNA-GC biosensor
The electrochemical procedure for the investigation of the
QPhNO2-dsDNA interaction involved three steps: preparation of
the electrode surface, immobilization of dsDNA gel and voltam-
metric transduction, as previously described (De Abreu et al.,
2008; Diculescu et al., 2005). For each series of experiments, an
identical dsDNA-GC electrode was prepared as a reference blank
to serve as a control. This electrode was not treated with substrate
but received the same pre- and post-treatments as the test elec-
trode. The procedure produced a thick-layer dsDNA-modiﬁed
electrode.
2.8. Interaction of dsDNA-GC biosensor with QPhNO2
Two different protocols were used to examine the interaction of
QPhNO2 with the biosensor. In the ﬁrst method, the dsDNA-GCsurface was dried under a stream of nitrogen, after which the
electrode was coated with 20 lL of a solution of QPhNO2 in ethanol
P.A., allowed to rest for 5 min and then dried again under a stream
of nitrogen until the gel was completely dry. After this step, 5 mL of
acetate buffer was added to the cell, and DPV experiments were
conducted. In the second method, the biosensor was immersed in
a solution of QPhNO2 (5, 10 or 20 lM) for 15 min, after which elec-
trochemical measurements were taken immediately. The same
procedure was also applied to the biosensor immersed only in ace-
tate buffer.
2.9. Interaction of ssDNA with QPhNO2
Single-stranded DNA (ssDNA) was prepared by dissolving
3.0 mg of dsDNA in 1.0 mL of chloridric acid (1 M) and heating
for 1 h until complete dissolution. This treatment was followed
by neutralizing the solution with 1.0 mL of sodium hydroxide
(1 M) and adding 9 mL of acetate buffer (Diculescu et al., 2005).
Freshly prepared ssDNA solution was added to the cell, and sin-
gle-scan DPV experiments were conducted in the range of 0 to
+1.4 V vs. AgAgCl, Cl (0.1 M). Two peaks corresponding to the oxi-
dation of the guanine and adenine bases appeared at potentials of
+0.815 V and +1.131 V, respectively. After the ﬁrst run, the elec-
trode was washed, polished and returned to the ssDNA solution.
After cleaning the surface, the GC electrode was inserted into a
solution containing QPhNO2 (at different concentrations of 5–
46 lM) and ssDNA, and the DPV experiment was repeated. A clean
GC electrode was also employed in the DPV experiments involving
a 20 lM solution of QPhNO2 alone, and the current of peak Ia was
used for comparison.
2.10. Statistical analysis
The IC50 values for the MTT assay were obtained by nonlinear
regression using the GRAPHPAD program (Intuitive Software for
Science, San Diego, CA) from 3 to 4 independent experiments per-
formed in triplicate.
The data are presented as the means ± S.D. from three indepen-
dent experiments. Differences between experimental groups were
compared by one-way ANOVA followed by Newman–Kells test for
multiple comparison (p < 0.05), whereas Student’s t tests were
used to compare data obtained in the absence or presence of
NAC (p < 0.05).
3. Results and discussion
3.1. Cytotoxicity against the leukemia cell line HL-60
The inhibitory effects of nor-beta and its nitrophenylamine
derivative QPhNO2 were initially determined on the growth of
HL-60 cells. The HL-60 cell line could be considered a suitable
model to study compounds derived from beta-lapachone because
588 A.J. Araújo et al. / Toxicology in Vitro 26 (2012) 585–594the cytotoxic effects and apoptosis-inducing properties of this
compound have already been demonstrated using this cell line
(Planchon et al., 1995, 1999).
As shown in Table 1, both QPhNO2 and nor-beta exhibited a
strong inhibitory effect on HL-60 cell proliferation after 24 h of
incubation, with IC50 values of 0.32 and 2.01 lM, respectively,
while doxorubicin showed an IC50 value of 0.22 lM (Table 1).
These ﬁndings are in agreement with a previous publication show-
ing the effects of these compounds in HL-60 cells but only after a
longer incubation period of 72 h (da Silva Júnior et al., 2007). The
introduction of the meta-nitrophenylamine group in C-3 of nor-
beta, leading to QPhNO2, could increase its growth inhibitory ef-
fects toward HL-60 cells, regardless of the incubation period. It is
interesting to note that while QPhNO2 presents a higher IC50 value
(0.91 lM) after 72 h incubation, the other quinones, nor-beta and
doxorubicin, presented a clear time-dependency, increasing their
activity after 72 h.
Quinones are redox active molecules that form semiquinones
and hydroquinones that can redox cycle in the presence of oxygen,
leading to the formation of reactive oxygen species (ROS) (Asche,
2005; de Abreu et al., 2002a; Hillard et al., 2008; Ferreira et al.,
2009). In fact, it is postulated that ROS generation and the alkyl-
ation of cellular nucleophiles, including DNA and enzymes with a
–SH group, account for the mechanism of cytotoxic action of drugs
containing a quinone moiety (Asche, 2005; de Abreu et al., 2002a;
Hillard et al., 2008; Ferreira et al., 2009).
In view of this fact, we measured the cytotoxic effect of QPhNO2
in the presence of NAC, an antioxidant that acts as a ROS scavenger
(Zafarullaha et al., 2003). The IC50 value for QPhNO2 increased from
0.32 to 1.03 lM and that for nor-beta increased from 2.01 to
2.72 lM (Table 1, column 3). While these data suggest the partic-
ipation of ROS in QPhNO2 cytotoxic effects, they do not exclude
other direct targets. Doxorubicin effects, in contrast, were not af-
fected by NAC treatment (Table 1). ROS production was also eval-
uated in HL-60 cells by ﬂow cytometry using the oxidation-
sensitive ﬂuorescent dye H2-DCF-DA after 1 h of incubation.
QPhNO2 and nor-beta stimulated ROS generation, while doxorubi-
cin was inactive (Fig. 2). ROS generation was higher in the ﬁrst
hour than after 3 h of incubation (data not shown). The pre-incuba-
tion with NAC protected the cells from oxidative stress, reducing
intracellular ROS generation.
Cell death can be classiﬁed according to its morphological
appearance, which may be apoptotic, necrotic, autophagic or asso-
ciated with mitosis catastrophe (Melino, 2001; Okada and Mak,
2004). Cells undergoing apoptosis show typical well-deﬁned mor-
phological changes, including plasma membrane blebbing,
chromatin condensation with margination of chromatin to the
nuclear membrane, karyorrhexis (nuclear fragmentation), andFig. 2. Intracellular reactive oxygen species generation caused by QPhNO2 and nor-
beta in HL-60 cells, after 1 h incubation. The negative control (Control) was the
vehicle used for diluting the tested substance. Doxorubicin and beta-lapachone (b)
were used as positive controls. Data are presented as mean values ± S.E.M., from
three independent experiments performed in triplicate. (a) p < 0.05 compared to
control by ANOVA, followed by Newman–Keuls Multiple Comparison Test. (b)
p < 0.05 comparison for each drug in the presence and in the absence of N-acetyl-L-
cysteine (NAC, 5 mM) by Student t test.formation of apoptotic bodies (Kerr et al., 1972), as already de-
scribed. Cells treated with QPhNO2 displayed those features, sug-
gesting that this compound induces apoptosis in HL-60 leukemia
cells (data not shown).
Considering the observed morphological features, we con-
ducted a ﬂow cytometry analysis of several cellular and biochem-
ical events to assess the mechanisms involved in cell death induced
by the tested compounds. In the initial stages of apoptosis, the cell
shrinks while the membrane remains intact; however, necrotic cell
swelling occurs as a result of the early failure of membrane integ-
rity (Darzynkiewicz et al., 1992; Ziegler and Groscurth, 2004). Nor-
beta and QPhNO2 reduced the density of HL-60 cells in a concen-
tration-dependent manner (Fig. 3A). Additionally, both compounds
induced internucleosomal DNA fragmentation (Fig. 3C), whereas
membrane disruption was only observed in the presence of
QPhNO2 at 1 and 2 lM (Fig. 3B).
Apoptosis was conﬁrmed by phosphatidylserine (PS) external-
ization, caspase 3 and 7 activation and DNA laddering (Figs. 4
and 5). QPhNO2 was again shown to be more active than its proto-
type nor-beta. Necrosis was also observed in QPhNO2-treated cells
(1 and 2 lM), which is compatible with the previously observed
loss of membrane integrity. However, it is not possible to state
whether necrotic cells corresponds to a secondary necrosis that oc-
curs later in the apoptotic process.
Caspases are essential molecules in apoptosis. Among them,
caspase 3 is the death promoter protease that can be activated
either by a dependent or independent mitochondrial cytochrome
c release and caspase 9 function. Additionally, caspase 3 is essential
for some hallmarks of apoptosis, such as chromatin condensation
and formation of apoptotic bodies. Several authors have reported
that beta-lapachone induces apoptosis in cancer cell lines at
5 lM (Gupta et al., 2002; Planchon et al., 1995). Therefore, for
the ﬁrst time, we report that both compounds induce apoptosis,
as observed by phosphatidylserine externalization, caspase 3 and
7 activation and DNA fragmentation.
ROS have been recognized as key molecules, which can selec-
tively modify proteins and thus regulate cellular signaling, includ-
ing apoptosis. A variety of anticancer agents induce apoptosis
through the generation of ROS (Eskes et al., 2000; Mizutani et al.,
2002). ROS generation is also known to contribute to mitochon-
drial damage, in which pro-apoptotic proteins from the cytosol
are translocated and integrated into the outer mitochondrial mem-
brane, leading to the formation of pores that release cytochrome c;
the cytochrome c then binds to APAF-1 and caspase 9, forming a
complex called the apoptosome, which leads to activation of cas-
pase 3 (Eskes et al., 2000; Li et al., 1997). In this context, the gen-
eration of ROS should present a role in the initiation of the
apoptotic process induced by QPhNO2. It is important to note that
doxorubicin is a poor pro-oxidant when compared with QPhNO2
and nor-beta, suggesting a different mechanism of action for this
molecule.
To evaluate the role of ROS in the apoptosis-inducing properties
of the tested compounds, the cells were pre-treated with NAC at
5 mM. The QPhNO2 effects on cell number (Fig. 3A), DNA fragmen-
tation (Fig. 3C), membrane integrity (Fig. 3B) and phosphatidylser-
ine externalization (Fig. 4) at a concentration of 0.5 lM were
inhibited after pre-treatment with NAC (Figs. 3 and 4), whereas
at 1 and 2 lM, QPhNO2 effects remained unaltered. These ﬁndings
reinforce the importance of oxidative stress in the apoptosis pro-
cess triggered by this molecule. However, they strongly suggest
additional targets because while NAC abolished ROS generation
induced by QPhNO2 at 1 and 2 lM (Fig. 2), it did not inhibit the
appearance of apoptotic features at the equal concentrations
(Figs. 3 and 4).
DNA is also recognized as a target of quinones. The cytotoxic
effects of doxorubicin are generally related to its ability to damage
Fig. 3. Effect of QPhNO2 and nor-beta in HL-60 cell density of cells (A) and cell membrane integrity (B) using propidium iodide; internucleosomal DNA fragmentation using
propidium iodide, Triton X-100 and citrate (C) determined by ﬂow cytometry after 24 h incubation. Doxorubicin (Dox, 0.5 lM) was used as a positive control. The negative
control (Control) was the vehicle used for diluting the tested substance. Five thousand events were analyzed in each experiment. Data are presented as mean values ± S.E.M.
from three independent experiments performed in triplicate. (a) p < 0.05 compared to control by ANOVA, followed by Newman–Keuls Multiple Comparison Test. (b) p < 0.05
comparison for each drug in the presence and in the absence of N-acetyl-L-cysteine (NAC, 5 mM) by Student t test.
Fig. 4. QPhNO2 (0.5, 1 and 2 lM) and nor-beta (2 lM) induces phosphatidylserine
(PS) externalization. PS externalization was determined by ﬂow cytometry using
Annexin V–PE and 7-AAD after 24 h of incubation in the absence and presence of N-
acetyl-L-cysteine (5 mM). The negative control (Control) was the vehicle used to
dilute the tested substance. Doxorubicin (Dox, 0.5 lM) was used as a positive
control. The percentages of early and late apoptotic and viable cells are indicated.
Data are presented as mean values ± S.E.M. from three independent experiments
performed in triplicate. Five thousand events were analyzed in each experiment. (a)
p < 0.05 compared to control by ANOVA, followed by Newman–Keuls Multiple
Comparison Test. (b) p < 0.05 comparison for each drug in the presence and in the
absence of N-acetyl-L-cysteine (NAC, 5 mM) by Student t test.
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bition of DNA topoisomerase II, its induction of double-stranded
DNA breaks, and its direct intercalation into DNA, modifying heli-
cal torsion (Ozben, 2007).
The comet assay is a sensitive and relatively simple technique
to quantify DNA damage in individual cells (Singh et al., 1988).
HL-60 cells treated with nor-beta did not display any DNA damage
in the tested time frame and dosage. QPhNO2 showed a different
proﬁle, with concentration-dependent damage and frequency of
damage after 3 and 24 h of treatment, especially at higher concen-
trations (10 lM) (Fig. 6). Doxorubicin, as expected, was a very
strong genotoxic compound, increasing the DNA damage index
and frequency at 0.5 lM (Fig. 6). Thus, QPhNO2 directly interacts
with DNA but at higher concentrations than those necessary to in-
duce apoptosis.3.2. Electrochemical experiments
Electrochemical methods (analytical and preparative) and elec-
trochemical (thermodynamic and kinetic) parameters have been
shown to be extremely useful in biomedical chemistry withrespect to the mechanisms of biological electron-transfer pro-
cesses. The high versatility of electrochemical methodologies
allows the mimicking of a large spectrum of biological environ-
ments (Hillard et al., 2008). With this in mind, electrochemical
proof of the pro-oxidant activity of QPhNO2 and nor-beta was
assayed using cyclic voltammetry in the presence of oxygen in
aprotic media, which provided a good model of the membrane
environment in which peroxidation processes take place (Ossowski
et al., 2000). The electrochemistry of both quinones in aprotic med-
ia on GCE and mercury has already been reported (de Souza et al.,
2010; Hernández et al., 2008). A detailed study of the inﬂuence of
oxygen concentration on EpIc and IpIc of both quinones was per-
formed, as described previously for lapachol and isolapachol
(Goulart et al., 2003, 2004). The addition of O2 to the system caused
remarkable changes to the position of the ﬁrst reduction peak po-
tential (EpIc) as well as to the shape of the other waves of QPhNO2
(Fig. 7A). The peak of oxygen reduction (EpO2) in this medium oc-
curred at 0.894 V. These effects include a) an increase in the
height and anodic shift of the ﬁrst cathodic wave (Ic) (inset,
Fig. 7A, which is related to the generation of the semiquinone,
and b) a disappearance of the corresponding anodic wave (Ia)
(Fig. 7A).
The position of the QPhNO2 ﬁrst reduction peak changed and
shifted toward more positive potentials (D = 0.032 V) with oxygen
concentration (Fig. 7A). The larger shift (D ca. 0.048 V) occurred at
an oxygen/QPhNO2 concentration ratio of 0.093. The reduction cur-
rent increased by 28% at oxygen concentrations as low as
0.096 mM and reached its maximum, with a 162% increase, in
[O2] = 0.806 mM (Fig. 7A, inset).
Data obtained from the addition of oxygen at different concen-
trations (Fig. 7B) indicate that the apparent association constant
between the electrogenerated semiquinone (from QPhNO2) and
O2 from the graph IpR1/IpO1 vs. kapp[O2]RT/nFv is 0.72 s1, consid-
ering that the maximum solubility of oxygen in DMF is 1.85 mM at
25 C (de Abreu et al., 2007). In similar experiments and conditions,
the apparent association constant for nor-beta is 0.55 s1 (Fig. 7C),
which is lower than that of QPhNO2.
In this study, using electrochemical methods, we have demon-
strated that the anion radicals of both quinones [nor-betaQ]
and [Q]-PhNO2 interact with O2 according to an EC mechanism,
which yields the original quinone and peroxyl radicals (Goulart
et al., 2003, 2004). These facts support the possible intermediacy
of ROS in the molecular mechanism of action of QPhNO2.
Fig. 5. Apoptosis-inducing effects of QPhNO2 and nor-beta at 2.0 lM in HL-60 cells. (A) Mitochondrial depolarization using rhodamine 123 (B) Caspases 3/7 activity was also
determined by ﬂow cytometry using FAM and 7-AAD. The negative control (Control) was the vehicle used for diluting the tested substances. Doxorubicin (Dox, 0.5 lM) was
used as a positive control. Data are presented as mean values ± S.E.M. from three independent experiments performed in triplicate. Three thousand events were analyzed in
each experiment. ⁄p < 0.05 compared to control by ANOVA followed by Newman–Keuls Multiple Comparison Test. (C) DNA laddering analysis of HL-60 cells that had been
treated with nor-beta at 2 lM (line 3), Dox at 0.5 lM (line 5) and QPhNO2 at 2 lM (line 4) after 24 h incubation. Negative control cells (line 2) were treated with vehicle alone.
Line 1: Marker 1 bp.
Fig. 6. Effect of QPhNO2 (0.5 up to 10 lM), nor-beta (2.0 and 10 lM) and doxorubicin (Dox) on DNA damage index (3 h, A and 24 h, C) and on DNA damage frequency (3 h, B
and 24 h, D) in comet assay. HL-60 cells were exposed for 3 h and 24 h. Bars represent the mean ± SEM of three independent experiments. ⁄p < 0.05, ANOVA followed by
Student–Newman–Keuls test.
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electrochemical studies in protic medium could provide valuable
information. CV and DPV of 0.1 and 1 mM solutions of QPhNO2
were performed. As shown in Fig. 8A, QPhNO2 demonstrated a
behavior represented by two reduction peaks (EpIc = 0.256 V
and EpIIc = –0.826 V) and the corresponding oxidation peaks(EpIa = –0.098 V, EpIIa = +0.072 V). In comparison with the CV of
nor-beta (da Silva Júnior et al., 2009) and beta-lapachone (de Abreu
et al., 2002b) and considering the facility of quinone reduction, it is
suggested that the ﬁrst reduction peak observed (Ic) for QPhNO2
(Fig. 8A) is related to the reduction of quinone by 2e/2H+ capture,
whereas the second stage of reduction (IIc) is related to the
Fig. 7. Cyclic voltammograms (CV) on glassy carbon electrode (3 mm diameter), in DMF + TBABF4, 0.1 M, t 0.100 V s1. (A) CV of QPhNO2 (cQPhNO2 = 1 mM), in the absence and
presence of oxygen at 0.100 V s1. (Inset) Effect of oxygen concentration on the peak current of the ﬁrst wave of reduction of QPhNO2 (Ip1c). (B) CV of QPhNO2
(cQPhNO2 = 1 mM), in the presence of different oxygen concentrations: (a) 0, (b) 0.096, (c) 0.131, (d) 0.165, (e) 0.200, (f) 0.237, (g) 0.318, (h) 0.806, (i) 1.42 mM. Inserted curve
Ip1c/Ip1a depending on the concentration of oxygen. (C) CV of nor-beta (cnor-beta = 1 mM). Same conditions, different oxygen concentrations: (a) 0, (b) 0.075, (c) 0.125, (d) 0.184
and (e) 0.246 mM.
Fig. 8. CV of QPhNO2 (cQPhNO2 = 0.1 mM), on glassy carbon electrode (3 mm diameter), in acetate buffer (0.1 M) + EtOH (50%) (pH 4.5), at 0.100 V s1. (A) Cathodic run, from
0.3 V up to 1.2 V. (B) Differential pulse voltammogram (DPV) of QPhNO2 (cQPhNO2 = 0.1 mM), anodic run, from 0 to +1.5 V measured with a pulse amplitude of 50 mV, a
pulse width of 70 ms and scan rate of 5 mV s1.
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trance of 4e/4H+ (Cavalcanti et al., 2004; Goulart et al., 2007).
The electrogenerated hydroxylamine (oxidation peak IIa) was also
shown to be unstable, whereas the expected electrochemical sys-
tem ArNHOH ¡ ArNO + 2H+ + 2e was not visible (second cycle,
inset, Fig. 8A).
The oxidation behavior of QPhNO2 (Fig. 8B) was represented by
one irreversible and diffusion-controlled process (EpIIIa shifted
with scan rate): in the DPV, peak IIIa was located at +0.884 V and
was likely related to the oxidation of the aromatic amino group
in the molecule, whereas nor-beta did not show oxidation peaks
(data not shown).
The interaction between QPhNO2 and dsDNA was analyzed
using thick-ﬁlm dsDNA-biosensors (Fig. 9); undesirable binding
of drug molecules to the electrode surface was avoided bycompletely covering the electrode surface with dsDNA (de Abreu
et al., 2008).
Despite the presence of the oxidation wave of QPhNO2 at a po-
tential very close (EpIIIa = + 0.884 V) to that of guanosine (approx-
imately +0.80 V vs. Ag/AgCl), a DNA-constituent base, it was
possible to observe a positive interaction, which was indicated
by the presence of the waves of guanosine and adenosine, using
a very low concentration of QPhNO2 (Fig. 9A and B) due to solubil-
ity problems.
The positive interaction between QPhNO2 and ssDNA in solu-
tion is depicted in Fig. 10. Signals associated with the oxidation
of the guanine (G) and adenine (A) bases (+0.83 V and +1.16 V vs.
Ag/AgCl 0.1 M, respectively) in ssDNA were very intense. However,
in the presence of QPhNO2, the current intensity of the oxidation
peaks decreased in a concentration-dependent manner until the
Fig. 9. Aqueous acetate buffer 0.2 M; pH 4.5. (A) DPV recorded following 15 min of exposure of a dsDNA biosensor to different concentrations of QPhNO2; (B) DPV of QPhNO2,
cQPhNO2 = 20 lM, on glassy carbon electrode. Peak Ia is related to the oxidation of QPhNO2 and the peaks associated with the oxidation of guanosine and adenosine are marked
with arrows.
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was precluded by dissolution problems, with the precipitation of
QPhNO2. The oxidation potentials of guanine and adenine were
kept nearly constant.
A different behavior (currents related to the oxidation of guan-
ine and adenine remained practically unaltered at concentrations
up to 200 lM) was reported for nor-beta (Cavalcanti et al., 2011)
in studies with ssDNA, and these results suggest that those com-
pounds do not damage DNA directly (Brett et al., 2002; de Abreu
et al., 2002a,b).
The positive correlation between the electrochemical and phar-
macological experiments can be expanded using already reported
data obtained from doxorubicin analogs. The interaction of dsDNA
(calf thymus) and daunorubicin in solution and on the electrode
surface was previously studied using cyclic voltammetry and
particularly by constant-current chronopotentiometric stripping
analysis using carbon paste electrodes, which revealed the interca-
lation of this drug between the base pairs in dsDNA (Wang et al.,
1998). Adriamycin, a cancerostatic anthracycline antibiotic, causesFig. 10. Differential pulse voltammograms (DPV), aqueous ethanol (27%), acetate buffer (
(A) Effects on ssDNA of increased amounts of QPhNO2, both in solution: (a) 0, (b) 0.005
oxidation of ssDNA, depending on the concentration of QPhNO2. (D) Effects on ssDNA of in
(f) and (a) only ssDNA solution.considerable tumor cell death, together with the induction of
breaks in single- and double-stranded DNA. The interaction of adri-
amycin with DNA was also investigated using an electrochemical
DNA-biosensor. Its intercalation in DNA disrupts the double helix,
and the detection of guanine and 8-oxoguanine could mimic a pos-
sible mechanism for the in vivo adriamycin drug action (Piedade
et al., 2002). Recently, Cavalcanti and coworkers reported the posi-
tive interaction between doxorubicin and ssDNA (Cavalcanti et al.,
2011).
As previously shown with respect to DNA, electrochemical
studies indirectly allow evidencing the generation of ROS. Experi-
ments performed in the presence of oxygen showed that QPhNO2
reacts faster with oxygen than nor-beta and provokes a greater re-
lease of ROS. These ﬁndings corroborate with those obtained by
ﬂow cytometry. The underlying rationale for this fact may be the
structure of the reduced nitroquinone (de Souza et al., 2010; Her-
nández et al., 2008). The redox-cycling of quinones may be initi-
ated by either a one- or two-electron reduction. The one-electron
reduction of quinones is catalyzed by NADPH–cytochrome P4500.1 mol L1), pH 4.5. Glassy carbon electrode vs. Ag|AgCl|Cl (0.1 M), m = 0.010 V s1.
, (c) 0.010, (d) 0.020, (e) 0.030, (f) 0.046 mM. (B and C) Graphs of peak current of
creased amounts of nor-beta: 0.010 (b), 0.020 (c), 0.060 (d), 0.100 (e) and 0.200 mM
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transfer electrons to molecular oxygen and return to their original
quinoidal formation, thus generating a superoxide anion radical
(O2). Superoxide can dismutate into hydrogen peroxide (H2O2)
by a SOD-catalyzed reaction, and a hydroxyl radical (HO) would
be subsequently formed by the iron-catalyzed reduction of perox-
ide by a Fenton reaction (Hillard et al., 2008). All of these highly
reactive ROS may react directly with DNA or other cellular macro-
molecules, such as lipids and proteins, leading to cell damage.4. Conclusions
In conclusion, QPhNO2 cytotoxicity is based on apoptosis, which
is partially caused by ROS release, and DNA is also a target for this
nitroquinone. This study illustrates how electrochemistry, bio-
chemistry and pharmacology can be integrated to elucidate biolog-
ical mechanisms of action.Conﬂict of interest
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